DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy.

Author(s): Mazzolai L, Hohlfeld P, Spertini F, Hayoz D, Schapira M, Duchosal MA

Affiliation(s): Service of Vascular Medicine, University Hospital of Lausanne (CHUV), Av Pierre Decker 5, 1011 Lausanne, Switerland. lucia.mazzolai@chuv.ch

Publication date & source: 2006-09-01, Blood., 108(5):1569-70. Epub 2006 Apr 27.

Publication type: Case Reports

Heparin is the drug of choice for the treatment or the prevention of thromboembolic disease during pregnancy. However, treatment options are limited when heparin cannot be used because of hypersensitivity skin reactions. Despite the recent availability of new anticoagulant agents, data relating to their use during pregnancy are lacking. This report describes the successful management with fondaparinux, during 150 days, of a pregnant patient with protein S deficiency and prior deep vein thrombosis (DVT) who developed heparin and danaparoid hypersensitivity.

Page last updated: 2007-02-12

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017